35 results on '"Østergaard, Brian"'
Search Results
2. Brain glucose metabolism in patients with newly diagnosed multiple myeloma significantly decreases after high-dose chemotherapy followed by autologous stem cell transplantation
3. Identification of Heterotopic Ossification Using 18F-NaF PET/CT
4. Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21
5. Prognostic significance of 18F-sodium fluoride in newly diagnosed multiple myeloma patients
6. Baseline global splenic uptake of FDG in multiple myeloma patients:a higher uptake is associated with inferior overall survival
7. Emerging techniques for assessment of multiple myeloma patients with PET/CT using FDG and NaF
8. Thoracic aorta atherosclerosis in multiple myeloma patients assessed by18F sodium fluoride PET/CT
9. Quantifying metabolic activity of the spleen in patient with multiople myeloma using 18F-FDG-PET/CT: comparison to normal subjects and evaluation of the effect of the high-dose chemotherapy
10. Assessment of bone turnover in multiple myeloma patients before and after treatment
11. Measuring bone marrow activity with FDG-PET in multiple myeloma, smoldering myeloma, and healthy subjects
12. Changes in bone marrow FDG uptake in multiple myeloma patients before and after treatment
13. Systemic bone modelling in multiple myeloma, smoldering myeloma, and healthy subjects: Global assessment with NaF-PET
14. Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)
15. FDG-PET/CT in multiple myeloma:dual time point imaging results can predict response to treatment in patients recieving high dose chemotherapy
16. Comparison of 18F-sodium fluoride uptake in the whole bone, pelvis, and femoral neck of multiple myeloma patients before and after high-dose therapy and conventional-dose chemotherapy.
17. FDG PET/CT in multiple myeloma:changed FDG uptake in the brain of patients receiving high dose chemotherapy
18. Effects of chemotherapy on brain glucose metabolism in patients with multiple myeloma
19. Global quantification of NaF in the skeleton:assessing bone formation in multiple myeloma patients before and after treatment
20. Increasing level of FDG uptake in shoulder, hip, and knee joints with aging:age related inflammation in the joints
21. NaF-PET/CT in multiple myeloma:assessing bone remodeling at baseline in newly diagnosed myeloma patients compared to a healthy control group
22. Correlation of Dual Time Point FDG-PET with Response to Chemotherapy in Multiple Myeloma
23. Quantification of the total bone marrow activity with FDG-PET in multiple myeloma before and after treatment:comparison with a control group
24. Myc protein overexpression is a feature of progression and adverse prognosis in multiple myeloma
25. FDG-PET/CT in multiple myeloma:Correlation between SUV and standard prognostic scoring system in multiple myeloma
26. FDG-PET/CT in multiple myeloma: Correlation between SUV and standard prognostic scoring system in multiple myeloma
27. Findings of Whole Body Computed Tomography Compared to Conventional Skeletal Survey in Patients with Monoclonal Plasma Cell Disorders:a Study of the International Myeloma Working Group
28. Myc protein expression in Multiple Myeloma: clinicopathological correlations and prognostic impact
29. 18F-FDG-PET/CT and Osteolytic Bone Disease in Multiple Myeloma
30. 18F-FDG-PET/CT in Multiple Myeloma: High Intense PET Positive Lesions at Diagnosis Harbor Cytogenetic Adverse Subclones
31. Smoldering multiple myeloma risk factors for progression:a Danish population-based cohort study
32. Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21
33. Smoldering multiple myeloma risk factors for progression: a Danish population-based cohort study.
34. Correlation of whole-bone marrow dual-time-point 18 F-FDG, as measured by a CT-based method of PET/CT quantification, with response to treatment in newly diagnosed multiple myeloma patients.
35. Prognostic significance of 18 F-sodium fluoride in newly diagnosed multiple myeloma patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.